Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Systemic lupus erythematosus

Recruiting

Registered drugNo placebo

Evaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Anifrolumab

Contact Research Centre

Cardiovascular disorder+1

Recruiting

Investigational

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:ZILEBESIRAN

Contact Research Centre

Systemic lupus erythematosus

Recruiting

Registered drug

Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Small cell lung cancer

Recruiting

Registered drugNo placebo

Safety and Tolerability of Alisertib Sodium and Paclitaxel in Patients with Small Cell Lung Cancer (Phase 2 Study)

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Alisertib Sodium

Contact Research Centre

Fallopian tube cancer+2

Recruiting

Registered drugNo placebo

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Myotonic dystrophy

Recruiting

Registered drug

A study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1

Registered drug

Spain

Participants:0–17 years · 18–64 years
Substances:Humanised Igg1 Kappa Fragment Antibody Targeting Tfr1 Conjugated To P125 Oligonucleotide

Contact Research Centre

Obesity+2

Recruiting

Investigational

A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

Investigational

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Obesity+2

Recruiting

Investigational

A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

Investigational

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Conjunctivitis allergic+1

Recruiting

Investigational

Study of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies

Investigational

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Dactylis Glomerata Pollen Extract

Contact Research Centre

Breast cancer+4

Recruiting

Registered drugNo placebo

Study of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Elacestrant

Contact Research Centre

Myotonic dystrophy

Recruiting

Registered drug

A study testing the safety and effects of ADS-019 in adults aged 18 to 65 years with type 1 myotonic dystrophy

Registered drug

Spain

Participants:18–64 years
Substances:ADS-019

Contact Research Centre

Myasthenia gravis

Recruiting

Registered drugNo placebo

A Study Comparing Nipocalimab and Efgartigimod for Adults with Generalized Myasthenia Gravis

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Find therapies in clinical trials near you

38 trials match your criteria

Systemic lupus erythematosus

Evaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus

Cardiovascular disorder+1

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Systemic lupus erythematosus

Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

Small cell lung cancer

Safety and Tolerability of Alisertib Sodium and Paclitaxel in Patients with Small Cell Lung Cancer (Phase 2 Study)

Fallopian tube cancer+2

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Myotonic dystrophy

A study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1

Obesity+2

A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

Obesity+2

A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

Conjunctivitis allergic+1

Study of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies

Breast cancer+4

Study of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer

Myotonic dystrophy

A study testing the safety and effects of ADS-019 in adults aged 18 to 65 years with type 1 myotonic dystrophy

Myasthenia gravis

A Study Comparing Nipocalimab and Efgartigimod for Adults with Generalized Myasthenia Gravis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.